CLINICAL_TRIALS
trial_result
· 2025-05-18
Clinical Trial Update: Test-retest Study With [18F]PI-2620 in PSP-RS and NDC [Phase 1]
Summary
Phase 1 test-retest study evaluating the PET tracer [18F]PI-2620 in Progressive Supranuclear Palsy with Richardson's syndrome (PSP-RS) completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Life Molecular Imaging GmbH | Conditions: Progressive Supranuclear Palsy | Phase 1 | Status: COMPLETED